-
FDA Approvals Summary - July 2025
FDA Drug Approvals
FDA approved several new drugs in July 2025, including treatments for phenylketonuria, chronic hand eczema, hereditary angioedema, EGFR-mutated lung cancer, and relapsed multiple myeloma, offering new hope for patients.
-
-
-
FDA Approvals Summary - April 2025
FDA Drug Approvals
Discover the FDA's new drug approvals in April 2025, including treatments for IgAN, nasopharyngeal carcinoma, myasthenia gravis, and colorectal cancer. Learn about groundbreaking therapies like Vanrafia, Penpulimab-KCQX, and Imaavy.
-
-
-
-
FDA Approved Summay - Januaray 2025
FDA Drug Approvals
Explore FDA drug approvals from January 2025, including treatments for Crohn's disease, colorectal cancer, Alzheimer's, migraine, and more. Key approvals from Eli Lilly, Amgen, AstraZeneca, and others reshape patient care options.
-
-
FDA 2025 Q1 Approval Overview (I)
FDA Drug Approvals
The FDA's 2025 Q1 approval pipeline includes promising treatments for diabetes, cancer, and central nervous system disorders. Key candidates include Ozempic for kidney disease, Subvenite for epilepsy, and TX05, a HER2-targeted cancer biosimilar.
远安县|
友谊县|
罗城|
张掖市|
泸定县|
鲁甸县|
周口市|
土默特左旗|
东至县|
晋州市|
大新县|
军事|
洞口县|
屏东县|
荥阳市|
静宁县|
吴江市|
钦州市|
关岭|
桐庐县|
赤水市|
牡丹江市|
小金县|
积石山|
康平县|
巢湖市|
拉孜县|
伽师县|
河津市|
淮南市|
胶州市|
安仁县|
得荣县|
贞丰县|
禄丰县|
外汇|
清徐县|
阿荣旗|
正蓝旗|
邢台市|
井陉县|